NCVH. Why Every Interventionist Must Understand PAD. Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

Size: px
Start display at page:

Download "NCVH. Why Every Interventionist Must Understand PAD. Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons"

Transcription

1 Why Every Interventionist Must Understand PAD NCVH New Cardiovascular Horizons KNOW YOUR OPTIONS Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA Clinical Professor of Medicine LSU School of Medicine New Orleans, LA Founder, President, and Medical Director Cardiovascular InsAtute of the South Houma, LA

2 DISCLOSURES Consultant/Medical/Scientific Boards Abbott Boston Scientific Cardiva Cook Medical CR Bard Lake Regional Medical Medtronic Spectranetics PVD Training Abbott Bard Boston Scientific Spectranetics TriReme Medical Stockholders CardioProlific Cardiva Spectrane5cs Vasamed Speaker s Bureau Abbo= Bard Boehringer- ingelheim Bristol- Myers- Squibb/Sanofi Cardiva Cook Medical Cordis DSI/Lilly Gore ACHL/Merck Spectrane5cs

3 There is an epidemic of PVD Mary Yost of the Sage Group estimates up to 20 million Americans have PVD. In 2006 between 1 million and 2.5 million people in the U.S. had CLI. (Estimated this will grow to 2.8 million by 2020). PAD is a marker for death with 1 year mortality or major CV event rates of 20%. The Majority of patients with PAD or either asymptomatic or ascribe their symptoms to etiologies other than PAD. THE OVERWHELMING MAJORITY OF PATIENTS WITH PAD ARE UNDIAGNOSED.

4 Prevalence of PAD in High-Risk Patients (PARTNER S Trial) 29%$of$pa)ents$were$diagnosed$ with$pad$defined$as$ankle: brachial$index$<0.9$ N= 6,979 Age > 70 years or years + diabetes or smoking 29% 44% 56% PAD only PAD and CAD Hirsch AT et al. JAMA. 2001;286:

5 Symptomatic And Asymptomatic PAD (PARTNER s Trial) Prior Diagnosed PAD (n=366) Newly Diagnosed PAD (n=457) No Symptoms Nonspecific Symptoms Claudica5on Hirsch AT et al. JAMA. 2001;286:

6 Patient Survival by Ankle-Brachial Index in Cardiovascular Health Study 1$ 0.9$ 0.8$ 0.7$ ABI>1.0$ ABI:$0.9$2$1.0$ ABI:$ $ ABI<0.8$ 0.6$ 0$ 1$ 2$ 3$ 4$ 5$ 6$ Newman et al ATVB 1999;19:

7 Five year mortality rates - PVD versus Cancer Five%Year%Mortality%Rates% Lung#Cancer## Colon/Rectal# PAD# Breast#cancer# 0%# 20%# 40%# 60%# 80%# 100%# *Criqui M. Presenta5on: Vascular Medicine of the Lower Extremi5es at the American Diabetes Associa5on s Scien5fic Sessions June 1999

8 Prognosis in Patients with Intermittent Claudication PopulaEon >55 yr IntermiNent ClaudicaEon Peripheral Vascular Outcomes Other Cardiovascular Morbidity/Total Mortality Worsening ClaudicaEon 16% Lower Extremity Bypass Surgery 7% Major AmputaEon 4% 4% vs Nonfatal Cardiovascular Event (MI/Stroke, 5- year Rate) 20% 42.5% 5- yr Mortality 30% Cardiovascular Cause 75% Adapted from Weitz JI et al. CirculaAon. 1996;94:

9 Ongoing Fibrin Formation and Degradation as a Function of ABI Trend for both: p<0.001 D-Dimer (ng/ml)! 2000" 1500" 1000" 500" 0" >1.1" 0.9)1.1" 0.7)0.9" 0.5)0.7" <0.5" CAD"(+)" CAD"())" Ankle-Brachial Index! McDermo= et al. Am J Cardiol 2003; 92:

10 Spontaneous Platelet Aggregation in Non-Coronary Vascular Disease Platelet AggregaEon (%) p< CONTROL CEA AAA PAD

11 A diminished foot pulse is often the only clue that a patient has advanced cardiovascular disease. One can not rely on symptoms to guide diagnosis and therapy.

12 Amputation - the far end of the spectrum BKA 5 8% perioperative mortality AKA 8 12% perioperative mortality Many require contralateral amputation within 1 yr Only 50% develop mobility post BKA Only 25% develop mobility post AKA 40% Amputees dead within 2 yrs We need aggressive limb salvage

13 Patient History 48 year old female s/p CABG 6 months prior Angiogram repeated x2 and reported normal Anterolateral defect on nuclear Worsening angina BP R arm 130/80 L arm 80/60 mm Hg.

14

15

16

17

18 Patient History 45 year old male referred for CABG from outside hospital. Known high grade brachiocephalic and lec subclavian stenosis and occluded lec common caro5d. High grade bilateral iliacs. Pt. developed crushing chest pain, diaphoresis, and dyspnea. Nurse called fran5c BP 50. I advised she give NTG she refused. I explained the BP was not representa5ve she s5ll refused. I arrived quickly and gave NTG, sx resolved

19

20

21

22

23

24

25 Patient History 51- year- old male with severe coronary artery disease requiring CABG, PVD with claudica5on and impotence CV surgeon wanted to operate stat CT angiography demonstrated occlusion of the bilateral iliac systems with unique collateral filling of the distal vessels

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43 Craig Walker, MD Houma, LA

44

45 Conclusions Diminished foot pulses may be the only clue of advanced ASCVD. Patients with PAD must be assessed globally PAD is associated with poor long term survival. PAD affects treatment. Patients with PAD must have longitudinal follow up. AMPUTATION SHOULD ALWAYS BE A LAST NOT FIRST RESORT

46 Closing Remarks / Thank You

Access (Antegrade, Retrograde, Pedal)

Access (Antegrade, Retrograde, Pedal) Access (Antegrade, Retrograde, Pedal) ARCH St. Louis Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA Clinical Professor of Medicine LSU

More information

State of the Art Cardiology and Advanced Limb Preservation Techniques

State of the Art Cardiology and Advanced Limb Preservation Techniques NCVH Baton Rouge: State of the Art Cardiology and Advanced Limb Preservation Techniques Faculty Craig M. Walker, MD, FACC, FACA, FACP, FSCAI, FASCI, FCCP, FICA (Chair) Founder, President and Medical Director,

More information

SAVE LIMBS SAVE LIVES!

SAVE LIMBS SAVE LIVES! SAVE LIMBS SAVE LIVES! PAD Awareness: The Key to Limb Preservation By Frank J Tursi, D.P.M., F.A.C.F.A.S. Epidemiology Over 12 million people are afflicted with PAD 11 Million of these-dm 4 Million DFU

More information

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound

Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Peripheral Artery Disease Interventions Utilizing the Angiosomal Approach to the Complex Wound Craig M. Walker, MD, FACC, FACP Chairman, New Cardiovascular Horizons Clinical Professor of Medicine Tulane

More information

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons What's New on the Vascular Horizons? NCVH New Cardiovascular Horizons KNOW YOUR OPTIONS Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans,

More information

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August Introduction to Peripheral Arterial Disease Stacey Clegg, MD Interventional Cardiology August 20 2014 Outline (and for the ABIM board exam * ** ***) Prevalence* Definitions Lower Extremity: Aorta*** Claudication***

More information

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,

More information

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of

More information

Now That You Have the Tools

Now That You Have the Tools blockosu@gmail.com Now That You Have the Tools Alan Jay Block, DPM, MS, FASPS, FACFAS Assistant Professor Dept Of Orthopeadics The Ohio State University Medical Board Kent State University Editor-in -Chief

More information

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease Role of ABI in Detecting and Quantifying Peripheral Arterial Disease Difference in AAA size between US and Surgeon 2 1 0-1 -2-3 0 1 2 3 4 5 6 7 Mean AAA size between US and Surgeon Kathleen G. Raman MD,

More information

DON T LET LEG PAIN BECOME A REAL THREAT.

DON T LET LEG PAIN BECOME A REAL THREAT. DON T LET LEG PAIN BECOME A REAL THREAT. These three words have the power to change lives. Between 8 to 10 million Americans are estimated to suffer from poor blood flow to the legs and feet potentially

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

Vascular screening in diabetic patients: how aggressive should we be and when to intervene?

Vascular screening in diabetic patients: how aggressive should we be and when to intervene? Vascular screening in diabetic patients: how aggressive should we be and when to intervene? Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy Disclosure Speaker name: ROBERTO FERRARESI X X

More information

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage George L. Adams, MD, MHS, MBA, FACC, FSCAI Clinical Associate Professor of Medicine University of North Carolina Health System Director

More information

Perfusion Assessment in Chronic Wounds

Perfusion Assessment in Chronic Wounds Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,

More information

Peripheral Arterial Disease: Who has it and what to do about it?

Peripheral Arterial Disease: Who has it and what to do about it? Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%

More information

Practical Point in Diabetic Foot Care 3-4 July 2017

Practical Point in Diabetic Foot Care 3-4 July 2017 Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University

More information

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Faculty Disclosure Thomas Zeller, MD For the 12 months preceding this presentation, I disclose the following types of

More information

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? Ehrin J. Armstrong, MD MSc MAS Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare

More information

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Vascular and Endovascular Management in Diabetic Vasculopathy Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery

More information

7 th Munich Vascular Conference

7 th Munich Vascular Conference 7 th Munich Vascular Conference Secondary prevention of major cardiovascular events in patients with CHD or PAD - What can we learn from EUCLID and COMPASS, evaluating Clopidogrel, Ticagrelor and Univ.-Prof.

More information

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter Patrick Muck, MD Chief, Division of Vascular Surgery Good Samaritan Hospital Cincinna

More information

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

What s New in the Management of Peripheral Arterial Disease

What s New in the Management of Peripheral Arterial Disease What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My

More information

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott -

More information

New Cardiovascular Horizons. Tucson. Multidisciplinary Strategies for Optimal Cardiovascular Care. Arizona February 7, 2015

New Cardiovascular Horizons. Tucson. Multidisciplinary Strategies for Optimal Cardiovascular Care. Arizona February 7, 2015 New Cardiovascular Horizons Tucson Multidisciplinary Strategies for Optimal Cardiovascular Care Arizona February 7, 2015 Chairmen: Miguel Montero-Baker, Salvatore J. Tirrito, Craig M. Walker, Course Directors:

More information

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:

More information

Pedal Bypass With Deep Venous Arterialization:

Pedal Bypass With Deep Venous Arterialization: Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj

More information

Recent Advances in Peripheral Salvage

Recent Advances in Peripheral Salvage Recent Advances in Peripheral Salvage Dr Shaiful Azmi Yahaya, MD, MMed, FNHAM, FAsCC, FAPSIC Consultant Cardiologist and Peripheral Interventionist, Institut Jantung Negara Disclosure I am proctoring for

More information

New Cardiovascular Horizons. Baton Rouge. State of the Art Cardiology and Advanced Limb Preservation Techniques. Louisiana January 24, 2015

New Cardiovascular Horizons. Baton Rouge. State of the Art Cardiology and Advanced Limb Preservation Techniques. Louisiana January 24, 2015 New Cardiovascular Horizons Baton Rouge State of the Art Cardiology and Advanced Limb Preservation Techniques Louisiana January 24, 2015 Chairmen: Deepak Thekkott, MD Craig M. Walker, MD TABLE OF CONTENTS

More information

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

Evidence-Based Optimal Treatment for SFA Disease

Evidence-Based Optimal Treatment for SFA Disease Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular

More information

Photoablation and DCB in in-stent restenosis

Photoablation and DCB in in-stent restenosis Photoablation and DCB in in-stent restenosis Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans, LA Clinical Professor of Medicine LSU School

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

Guidelines for Management of Peripheral Arterial Disease

Guidelines for Management of Peripheral Arterial Disease Guidelines for Management of Peripheral Arterial Disease Subhash Banerjee, MD, FACC, FSCAI Professor of Medicine, Univ. of Texas Southwestern Medical Center Chief, Division of Cardiology, VA North Texas

More information

Interventional Treatment First for CLI

Interventional Treatment First for CLI Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant

More information

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Practical Point in Holistic Diabetic Foot Care 3 March 2016 Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai

More information

USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential

USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential MEASURE STEWARD: The US Wound Registry [Note: This measure

More information

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC) W. Schuyler Jones, MD FACC Director, Adult Cardiac Catheterization Laboratory

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

Cath Lab Essentials : Peripheral Vascular Disease in Patients with CAD

Cath Lab Essentials : Peripheral Vascular Disease in Patients with CAD Cath Lab Essentials : Peripheral Vascular Disease in Patients with CAD Pranav M. Patel, MD, FACC, FSCAI Interim Chief & Associate Professor of Medicine Director, Cardiac Catheterization Lab University

More information

Diabetes and Occult Coronary Artery Disease

Diabetes and Occult Coronary Artery Disease Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York

More information

Imaging for Peripheral Vascular Disease

Imaging for Peripheral Vascular Disease Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right

More information

9/25/16. Disclosures. Risk Factors of PAD. Endovascular Management of PAD in the Female Patient

9/25/16. Disclosures. Risk Factors of PAD. Endovascular Management of PAD in the Female Patient 9/25/16 Endovascular Management of PAD in the Female Patient Richard C Kovach, MD, FACC, FSCAI, FACP Division Director, Intervention Cardiology Medical Director, Cardiac Catheterization Laboratory Assistant

More information

Use of Laser In BTK Disease (CLI)

Use of Laser In BTK Disease (CLI) Use of Laser In BTK Disease (CLI) Click to edit academic affiliation, practice or hospital logo(s) of preference. Product and/or sponsor logos not permitted, per CME guidelines. Richard Kovach, MD, FACC,

More information

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Interventional Cardiology and Cath Labs The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Manesh R. Patel MD Chief,

More information

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Chernyavskiy M.,MD,PhD, Chernova D., Zherdev N., Chernov A. Almazov National Medical Research Centre, St.Petersburg, Russia

More information

Cardiovascular Update for Primary Care Providers. Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD

Cardiovascular Update for Primary Care Providers. Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD Cardiovascular Update for Primary Care Providers Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD Agenda Lower Extremity pain Initial evaluation Treatment options of noncritical

More information

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the

More information

The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience

The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have

More information

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene

More information

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making Dr. Özgün Sensebat Vascular and general surgeon Vascular Private Clinic Dorsten

More information

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR Disclosure Speaker name: Jorge Fernández

More information

Medical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017

Medical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017 Medical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017 Objectives 1. Appreciate the long term implications of PAD 2. Appreciate the

More information

Wound and surgery-guided revascularization & flow-guided surgery: the multidisciplinary approach to limb salvage

Wound and surgery-guided revascularization & flow-guided surgery: the multidisciplinary approach to limb salvage Wound and surgery-guided revascularization & flow-guided surgery: the multidisciplinary approach to limb salvage Vincenzo Foppa, 1462 The miracle of the salvaged foot Cappella Portinari, S. Eustorgio Church

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

Cardiovascular Disease in CLI Patients

Cardiovascular Disease in CLI Patients L E I P Z I G I N T E R V E N T I O N A L C O U R S E 2 0 1 8 Nurse and Technician Forum - Part II Cardiovascular Disease in CLI Patients Corneliu Popescu Universitätsklinikum Leipzig Disclosure Speaker

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes Carlos Mena, MD FACC FSCAI Associate Professor of Medicine - Cardiology Director Cardiac

More information

TCD in Subclavian Steal Syndrome

TCD in Subclavian Steal Syndrome ISSN 2005-7881 Journal of Neurosonology 2(Suppl. 1):25-30, 2010 TCD in Subclavian Steal Syndrome Soon-Tae Lee, M.D., Ph.D. Department of Neurology, Seoul National University Hospital, Seoul, South Korea

More information

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue Robert M. Bersin, M.D. Director, Endovascular Services Seattle Cardiology and the Cardiovascular

More information

Preliminary 6-month results of VMI-CFA trial

Preliminary 6-month results of VMI-CFA trial Preliminary 6-month results of VMI-CFA trial Koen Deloose, MD Head Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium Disclosure slide Speaker name: Koen Deloose, MD I have the following potential

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

I am no good at debates!

I am no good at debates! Disclosure Statement of Financial Interest Imaging Strategy for Claudication: Ultrasound Alone is Not Adequate to Select Patients for Endovascular Intervention Within the past 12 months, I or my spouse/partner

More information

For No-Option patients, there is now another option. Dr. Michael Lichtenberg, Klinikum Arsnberg, Germany

For No-Option patients, there is now another option. Dr. Michael Lichtenberg, Klinikum Arsnberg, Germany From No Hope to New Hope For No-Option patients, there is now another option. Dr. Michael Lichtenberg, Klinikum Arsnberg, Germany Our Unique Solution The LimFlow system leverages a scientifically proven

More information

VDF and The Burden of Vascular Disease

VDF and The Burden of Vascular Disease VESSEL: The Annual Meeting of the VDF September 23,2012 VDF and The Burden of Vascular Disease David P. Faxon MD President Elect VDF Vice Chair of Medicine Brigham and Women s Hospital Disclosures: Boston

More information

Prevention of MACROvascular Complications of Diabetes

Prevention of MACROvascular Complications of Diabetes Prevention of MACROvascular Complications of Diabetes Matt Bouchonville, MD, CDE Endocrinology Division University of New Mexico School of Medicine July 12, 2018 Conflicts of Interest None Objectives 1.

More information

Detection of peripheral vascular disease in patients with type-2 DM using Ankle Brachial Index (ABI)

Detection of peripheral vascular disease in patients with type-2 DM using Ankle Brachial Index (ABI) Original article: Detection of peripheral vascular disease in patients with type-2 DM using Ankle Brachial Index (ABI) 1DR Anu N Gaikwad, 2 Dr Vikrant V Rasal, 3 Dr S A Kanitkar, 4 Dr Meenakshi Kalyan

More information

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS CRITICAL LIMB ISCHEMIA... 1 CONCLUSION... 9 U.S. CRITICAL LIMB ISCHEMIA PREVALENCE... 9 MARKET OPPORTUNITY ENDOVASCULAR... 9 MARKET OPPORTUNITY

More information

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral

More information

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

2-YEAR DATA SUPERA POPLITEAL REAL WORLD 2-YEAR DATA SUPERA POPLITEAL REAL WORLD Enrique M. San Norberto. Angiology and Vascular Surgery. Valladolid University Hospital. Valladolid. Spain. Disclosure Speaker name: ENRIQUE M. SAN NORBERTO I have

More information

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The

More information

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner

More information

AAIM TRIENNIAL COURSE 124 TH ANNUAL MEETING. The Broadmoor Colorado Springs, CO

AAIM TRIENNIAL COURSE 124 TH ANNUAL MEETING. The Broadmoor Colorado Springs, CO AAIM TRIENNIAL COURSE 124 TH ANNUAL MEETING The Broadmoor Colorado Springs, CO October 2015 MAJOR ARTERIAL DISEASES ROBERT LUND MD, DBIM Two Main Types of Major Arterial Disease Atherosclerotic Peripheral

More information

Peripheral Arterial Disease Extremity

Peripheral Arterial Disease Extremity Peripheral Arterial Disease Lower Extremity 05 Contributor Dr Steven Chong Advisors Dr Ashish Anil Dr Tay Jam Chin Introduction Risk Factors Clinical Presentation Classification History PHYSICAL examination

More information

Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes

Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Naveed Afzal, Sunghwan Sohn, Christopher G. Scott, Hongfang Liu, Iftikhar J. Kullo, Adelaide M. Arruda-Olson

More information

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE Michael S. Conte MD Professor and Chief, Vascular and Endovascular Surgery Co-Director, Center for Limb Preservation Co-Director, Heart and Vascular

More information

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

More information

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate

More information

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb

More information

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

More information

Peripheral Arterial Disease: Objectives. Disclosure. Definition: Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease: Objectives. Disclosure. Definition: Peripheral Arterial Disease (PAD) Geriatric Grand Rounds Tuesday, April 21, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this

More information

Non-invasive examination

Non-invasive examination Non-invasive examination Segmental pressure and Ankle-Brachial Index (ABI) The segmental blood pressure (SBP) examination is a simple, noninvasive method for diagnosing and localizing arterial disease.

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard? Disclosures Boston Scientific, Medical Advisory Board Endologix Corp., Consultant and trainer, AFX Aorto-Iliac Disease: Bare Metal, Covered or Stent Grafts How I Decide John S. Lane III MD, FACS Professor

More information

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial Prof. Thomas Zeller, MD Department Angiology Clinic for Cardiology and Angiology II University Heart-Center

More information

V.A. is a 62-year-old male who presents in referral

V.A. is a 62-year-old male who presents in referral , LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

Are RCT always needed: Experience with objective performance criteria (OPC)

Are RCT always needed: Experience with objective performance criteria (OPC) Are RCT always needed: Experience with objective performance criteria (OPC) Peter A. Schneider, MD Krishna Rocha-Singh, MD Kaiser Foundation Hospital Honolulu, Hawaii Prarie Heart Institute Springfield,

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Angiosome revascularization strategies in real world practice: how much difference does it make?

Angiosome revascularization strategies in real world practice: how much difference does it make? Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have

More information

Rotarex mechanical debulking: The Leipzig experience in patients

Rotarex mechanical debulking: The Leipzig experience in patients Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients Dierk Scheinert, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Dierk Scheinert

More information

FFR-CT Not Ready for Primetime

FFR-CT Not Ready for Primetime FFR-CT Not Ready for Primetime Leslee J. Shaw, PhD, MASNC, FACC, FAHA, FSCCT R. Bruce Logue Professor of Medicine Co-Director, Emory Clinical CV Research Institute Emory University School of Medicine Atlanta,

More information

Best Strategy is Still Out There: Bioresorbable Vascular Scaffold (BVS) and New Technology?

Best Strategy is Still Out There: Bioresorbable Vascular Scaffold (BVS) and New Technology? Best Strategy is Still Out There: Bioresorbable Vascular Scaffold (BVS) and New Technology? ARCH St. Louis Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Long-term results with interwoven nitinol stents vs. BMS vs. DCB

Long-term results with interwoven nitinol stents vs. BMS vs. DCB Long-term results with interwoven nitinol stents vs. BMS vs. DCB Dierk Scheinert, MD Division of Interventional Angiology University Hospital Leipzig, Germany Disclosure Advisory Board /Consultant: Abbott,

More information

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE

More information